Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 1, 1996, Pages 411-420

  Tennant, Marie K ^a,b   Thrasher, J Brantley ^c   Twomey, Patrick A ^c   Birnbaum, Roger S ^a   Plymate, Stephen R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; TISSUE DISTRIBUTION; TRANSLATION REGULATION;

ADENOCARCINOMA; AGED; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; KERATINS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 0030027259     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.1.411     Document Type: Article

References (46)

1. Daughaday WH, Rotwein P. 1989 Insulin-like growth factors 1 and 2. Peptide messenger ribonucleic acid, gene structures and serum and tissue concentrations. Endocr Rev. 10:68-91.
2. Daughaday WH. 1990 Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology. 127:1-4.
3. Rosenfeld RG, Lamson GL, Hung P, et al. 1990 Insulin-like growth factor binding proteins. Recent Prog Horm Res. 46:99-163.
4. Shimasaki S, Ling N. 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, -6). Prog Growth Factor Res. 3:243-266.
5. Clemmons D. 1992 IGF binding proteins: regulation of cellular actions. Growth Regul. 2:80-87.
6. Kratz G, Lake M, Ljungsrtom K, Forsberg G, Haegerstrand A, Gidlund M. 1992 Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: selective enhancement of IGF-I, but not IGF-II induced cell proliferation. Exp Cell Res. 202:381-385.
7. Andress D, Birnbaum R. 1992 Human osteoblast-derived insulin-like growth factor binding protein (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem. 267:22467-22472.
8. Bicsak T, Shimonaka M, Malkowsk M, Ling N. 1990 Insulin-like growth factor binding proteins (IGF-BP) inhibition of granulosa cell function: effect on cyclic adenosine 3′,5′-monophosphate, deoxyribonucleic acid synthesis, and comparison with the effect of an IGF-I antibody. Endocrinology. 126:2184-2189.
9. Cohen P, Okajima T, Rosenfeld RG. 1993 Transfection of the human insulin-like growth factor binding protein-3 gene into BALB/c fibroblasts inhibits cellular growth. Mol Endocrinol. 7:380-386.
10. Cohen P, Peehl DM, Lamson G, Rosenfeld RG. 1991 Insulin-like growth factors (IGFs), IGF receptors, and IGF binding proteins in primary cultures of epithelial cells. J Clin Endocrinol Metab. 73:401-407.
11. Fiorelli G, de Bellis A, Longo A, et al. 1991 Growth factors in the human prostate. J Steroid Biochem Mol Biol. 40:199-205.
12. Reiter E, Bonnet P, Sente B, et al. 1992 Growth hormone and prolactin stimulate androgen receptor, insulin-like growth factor-I (IGF-I) and IGF-I receptor levels in the prostate of immature rats. Mol Cell Endocrinol. 88:77-87.
13. Fiorelli G, de Bellis A, Longo A, et al. 1991 Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with n gonadotropin-releasing hormone analog. J Clin Endocrinol Metab. 72:740-746.
14. Barni T, Vannelli B, Sadri R, et al. 1994 Insulin-like growth factor-I and its binding protein IGFBP-4 in human prostatic hyperplastic tissue: gene expression and its cellular localization. J Clin Endocrinol Metab. 78:778-783.
15. Bonnet P, Reiter E, Bruyninx M, et al. 1993 Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5α-reductase and steroid hormone receptors messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J Clin Endocrinol Metab. 77:1203-1208.
16. Cunha GR, Donjacour AA, Cooke PS, et al. 1987 The endocrinology and developmental biology of the prostate. Endocr Rev. 8:338-362.
17. Chung LWK. 1991 Fibroblasts are critical determinants in prostate growth and dissemination. Cancer Metast Rev. 10:263-274.
18. Camps JL, Chang SM, Hsu TC, et al. 1990 Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA. 87:75-79.
19. Birnbaum R, Ware J, Plymate S. 1994 Insulin-like growth factor binding protein-3 expression and secretion by primary cultures of human prostate epithelial and stromal cells. J Endocrinol. 141:535-540.
20. Kaicer E, Blat, Harel L. 1991 IGF-I and IGF-binding proteins: stimulatory and inhibitory factors secreted by human prostatic adenocarcinoma cells. Growth Factors. 4:231-237.
21. Kaicer E, Blat C, Imbenotte J, et al. 1993 IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth. Growth Regul. 3:180-189.
22. Plymate SR, Thrasher JB, Ware JL, Drivdahl RH, Birnbaum RS. Insulin-like growth factor binding proteins differentailly affect the action of insulin-like growth factors-I and -II on human prostate epithelial cells. Proc of the 76th Annual Meet of The Endocrine Soc. 1994; 1395.
23. Cohen P, Peehl DM, Graves HC, Rosenfeld RG. 1994 Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol. 142:407-415.
24. Cohen P, Peehl D, Stamey T, Wilson K, Clemmons D, Rosenfeld R. 1993 Elevated levels of insulin-like growth factor-binding proteins-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab. 76:1031-1035.
25. Kanety H, Madjar Y, Dagan Y, et al. 1993 Serum Insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J Clin Endocrinol Metab. 77:229-233.
26. Petein M, Michel P, Velthoven RV, et al. 1991 Morphonnuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis. Am J Clin Pathol. 96:628-634.
27. McNeal JE. 1988 Significance of duct-acinar dysplasia in prostate carcinogenesis. Prostate. 13:91-102.
28. Bostwick DG. 1992 Prostatic intraepithelial neoplasia (PIN): current concepts. J Cell Biochem. 16(Suppl):10-19.
29. Brawer MK. 1992 Prostatic intraepithelial neoplasia. A premalignant lesion. Hum Pathol. 23:242-248.
30. Mostofi FK, Davis Jr CJ, Sesterhenn IA. 1993 Histopathology of prostate cancer. In: Lepor H, Lawson R, eds. Prostate diseases. Philadelphia: Saunders; 229-256.
31. Bonkhoff H, Stein U, Remberger K. 1994 The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate. 24:114-118.
32. Sherwood ER, Theyer G, Steiner G, Berg LA, Kozlowski JM, Lee C. 1991 Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate. Prostate. 18:303-314.
33. Verhagen APM, Ramaechers FCS, Aalders TW, Schaafsma HE, Debruyne FMJ, Schalken JA. 1992 Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res. 52:6182-6187.
34. Mostofi FK, Davis Jr CJ. 1990 Male reproductive system. In: Kissane M, ed. Anderson's pathology. St. Louis: Mosby; 907-915.
35. Camacho-Hubner C, Busby W, McCusker R, Wright G, Clemmons D. 1992 Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem. 267:11949-11956.
36. Reeve JG, Schwander J, Bleehen NM. 1993 IGFBP-2: an important regulator of insulin like growth factor action in human lung tumors. Growth Regul. 3:82-84.
37. Ross M, Francis GL, Szabo L, Wallace JC, Ballard FJ. 1989 Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-I. Biochem J. 258:267-272.
38. Schwander J, Mary J-L, Landwehr J, Boni M, Margot J, Binkert C. 1989 The regulation of mRNA of an insulin-like growth factor binding protein (IBP-2) in the rat. In: Drop SLS, Hintz RL, eds. Insulin-like growth factor binding proteins. Excerpt Med Int Congr Ser 881. Amsterdam: Elsevier; 125-131.
39. Delhanty PJD, Han VKM. An RGD to RGE mutation in the putative membrane binding domain of insulin-like growth factor binding protein-2 inhibits its potentiation of IGF-II induced thymidine uptake by SPC cells. Proc of the 75th Annual Meet of The Endocrine Soc. 1993; 56.
40. Bourner MJ, Busby WA, Seigel NR, Krivi GG, McCusker RH, Clemmons DR. 1992 Cloning and sequence determination of insulin-like growth factor binding protein-2 (IGFBP): comparison with IGFBP-I. J Cell Biochem. 48:215-226.
41. Jones JI, Gockerman A, Busby WH, Wright G, Clemmons DR. 1993 Insulin-like growth factor binding protein-1 stimulates cell migration and binds to the α5βN1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA. 90:10553-10557.
42. Cohen p, Graves H, Peehl D, Kamarei M, Giudice L, Rosenfeld R. 1992 Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab. 75:1046-1053.
43. Conover CK, Zapf MC. 1993 Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. J Clin Invest. 91:1129-1137.
44. Conover CA, Perry JE, Tindall DJ. 1995 Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor binding proteins in cultured human prostatic carcinoma cells. J Clin Endocrinol Metab. 80:987-993.
45. Marcelli M, Haidacher SJ, Plymate SR, Birnbaum RS. 1995 Altered growth and insulin-like growth factor binding protein-3 production in PC3 prostate carcinoma cells stabily transfected with a constitutively active androgen receptor complementary deoxyribonudeic acid. Endocrinolgy. 136:1040-1048.
46. Karasik A, Menczer J, Pariente C, Kanety H. 1994 Insulin-like growth factor-1 (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J Clin Endocrinol Metab. 78:271-716.